Cargando…
P1078: PATIENTS WITH HODGKIN LYMPHOMA DEVELOP ADEQUATE HUMORAL SEROLOGICAL RESPONSE TO VACCINATION WITH TWO DOSES OF BNT162B2 AND THEIR IGG ANTIBODY LEVELS MARKEDLY INCREASE AFTER A THIRD VACCINE DOSE
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429258/ http://dx.doi.org/10.1097/01.HS9.0000847180.34574.50 |
| _version_ | 1784779384483217408 |
|---|---|
| author | Dann, E. Inbar, T. Mashiach, T. Eisa, J. Ringelstein-Harlev, S. Horowitz, N. |
| author_facet | Dann, E. Inbar, T. Mashiach, T. Eisa, J. Ringelstein-Harlev, S. Horowitz, N. |
| author_sort | Dann, E. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429258 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94292582022-08-31 P1078: PATIENTS WITH HODGKIN LYMPHOMA DEVELOP ADEQUATE HUMORAL SEROLOGICAL RESPONSE TO VACCINATION WITH TWO DOSES OF BNT162B2 AND THEIR IGG ANTIBODY LEVELS MARKEDLY INCREASE AFTER A THIRD VACCINE DOSE Dann, E. Inbar, T. Mashiach, T. Eisa, J. Ringelstein-Harlev, S. Horowitz, N. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429258/ http://dx.doi.org/10.1097/01.HS9.0000847180.34574.50 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Dann, E. Inbar, T. Mashiach, T. Eisa, J. Ringelstein-Harlev, S. Horowitz, N. P1078: PATIENTS WITH HODGKIN LYMPHOMA DEVELOP ADEQUATE HUMORAL SEROLOGICAL RESPONSE TO VACCINATION WITH TWO DOSES OF BNT162B2 AND THEIR IGG ANTIBODY LEVELS MARKEDLY INCREASE AFTER A THIRD VACCINE DOSE |
| title | P1078: PATIENTS WITH HODGKIN LYMPHOMA DEVELOP ADEQUATE HUMORAL SEROLOGICAL RESPONSE TO VACCINATION WITH TWO DOSES OF BNT162B2 AND THEIR IGG ANTIBODY LEVELS MARKEDLY INCREASE AFTER A THIRD VACCINE DOSE |
| title_full | P1078: PATIENTS WITH HODGKIN LYMPHOMA DEVELOP ADEQUATE HUMORAL SEROLOGICAL RESPONSE TO VACCINATION WITH TWO DOSES OF BNT162B2 AND THEIR IGG ANTIBODY LEVELS MARKEDLY INCREASE AFTER A THIRD VACCINE DOSE |
| title_fullStr | P1078: PATIENTS WITH HODGKIN LYMPHOMA DEVELOP ADEQUATE HUMORAL SEROLOGICAL RESPONSE TO VACCINATION WITH TWO DOSES OF BNT162B2 AND THEIR IGG ANTIBODY LEVELS MARKEDLY INCREASE AFTER A THIRD VACCINE DOSE |
| title_full_unstemmed | P1078: PATIENTS WITH HODGKIN LYMPHOMA DEVELOP ADEQUATE HUMORAL SEROLOGICAL RESPONSE TO VACCINATION WITH TWO DOSES OF BNT162B2 AND THEIR IGG ANTIBODY LEVELS MARKEDLY INCREASE AFTER A THIRD VACCINE DOSE |
| title_short | P1078: PATIENTS WITH HODGKIN LYMPHOMA DEVELOP ADEQUATE HUMORAL SEROLOGICAL RESPONSE TO VACCINATION WITH TWO DOSES OF BNT162B2 AND THEIR IGG ANTIBODY LEVELS MARKEDLY INCREASE AFTER A THIRD VACCINE DOSE |
| title_sort | p1078: patients with hodgkin lymphoma develop adequate humoral serological response to vaccination with two doses of bnt162b2 and their igg antibody levels markedly increase after a third vaccine dose |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429258/ http://dx.doi.org/10.1097/01.HS9.0000847180.34574.50 |
| work_keys_str_mv | AT danne p1078patientswithhodgkinlymphomadevelopadequatehumoralserologicalresponsetovaccinationwithtwodosesofbnt162b2andtheiriggantibodylevelsmarkedlyincreaseafterathirdvaccinedose AT inbart p1078patientswithhodgkinlymphomadevelopadequatehumoralserologicalresponsetovaccinationwithtwodosesofbnt162b2andtheiriggantibodylevelsmarkedlyincreaseafterathirdvaccinedose AT mashiacht p1078patientswithhodgkinlymphomadevelopadequatehumoralserologicalresponsetovaccinationwithtwodosesofbnt162b2andtheiriggantibodylevelsmarkedlyincreaseafterathirdvaccinedose AT eisaj p1078patientswithhodgkinlymphomadevelopadequatehumoralserologicalresponsetovaccinationwithtwodosesofbnt162b2andtheiriggantibodylevelsmarkedlyincreaseafterathirdvaccinedose AT ringelsteinharlevs p1078patientswithhodgkinlymphomadevelopadequatehumoralserologicalresponsetovaccinationwithtwodosesofbnt162b2andtheiriggantibodylevelsmarkedlyincreaseafterathirdvaccinedose AT horowitzn p1078patientswithhodgkinlymphomadevelopadequatehumoralserologicalresponsetovaccinationwithtwodosesofbnt162b2andtheiriggantibodylevelsmarkedlyincreaseafterathirdvaccinedose |